BioCentury
ARTICLE | Clinical News

Motrem: Phase I data

September 19, 2016 7:00 AM UTC

A double-blind, placebo-controlled Phase I trial in healthy volunteers showed that IV Motrem was well tolerated. Data will be presented at the International Sepsis Forum in Paris in December. ...